Original Source(s)
Related Content
Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial
An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.
by Teraya Smith
July 23, 2026
-
3 min
Can LAI-CAB Sustain Long-Term PrEP Use?
A national claims analysis found modest uptake and declining persistence over 2 years despite increasing use of injectable HIV pre-exposure prophylaxis.
July 17, 2026
-
4 min